This article cannot be shown due to contract restrictions.
At a glance
—
In Utah
Brigham Young University and professor Daniel Simmons sued Pfizer in 2006, saying Simmons had made a critical discovery that led to the development of Celebrex but that he and BYU had been denied a share of profits. Pfizer agreed to settle the case earlier this year for $450 million. That lawsuit was not associated with a pending securities fraud case against Pfizer.
![]() |
Join the Discussion |
![]() |
Post a Comment |
-
Blogger dropped from Pride Festival over Mormon comments
Published May 24, 2013 04:14:18PM -
Obama: Sexual assault threatens trust in military
Published May 24, 2013 04:03:02PM
Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.






